Broken Medical Science
Broken Medical Science, an evidence-based podcast series, launched in September 2023
We have a broken medical system. What documents this better than anything else is that our prescription drugs are the third leading cause of death, after heart disease and cancer. This would not be the case if drug regulators protected us against ineffective and harmful drugs. Furthermore, drug research in medical journals is often unreliable and doctors prescribe far too many drugs. On top of this, the COVID-19 pandemic has aggravated seriously the already existing scientific censorship, which has also been harmful.
In our podcast series, we interview top researchers, science journalists, consumer advocates and others that will tell you how we can do better and how you may improve your chances of living a long and happy life. The host is Professor Peter C Gøtzsche who has published over 100 articles in the world’s five most prestigious medical journals: BMJ, Lancet, JAMA, Annals of Internal Medicine, and New England Journal of Medicine.
Our audience is everyone with an interest in healthcare. We will provide links or references to reliable research discussed in the podcasts so that the viewers can check for themselves the veracity of what is being said. Our main topics are psychiatry, drugs, and vaccines. There are no ads and no censorship.
Eli Lilly’s clinical study reports on fluoxetine
Eli Lilly and Company. Protocol B1Y-MC-X065. Clinical study main report: Fluoxetine versus placebo in the acute treatment of major depressive disorder in children and adolescents. 2000; 8 August and Eli Lilly and Company. Protocol B1Y-MC-HCJE. Clinical study report: Fluoxetine versus placebo in childhood/adolescent depression. 2000; 6 August.
We describe these two study reports in: Gøtzsche PC, Healy D. Restoring the two pivotal fluoxetine trials in children and adolescents with depression. Int J Risk Saf Med 2022;33:385-408.
Maladministration at the European Medicines Agency: the HPV vaccines
Gøtzsche PC, et al. Complaint to to the European Medicines Agency (EMA) over maladministration at the EMA. Nordic Cochrane Centre 2016 May 26.
Organisations with similar visions as the Institute
Council for Evidence-based Psychiatry, London, UK. Communicates evidence of the harmful effects of psychiatric drugs.
Global Health Justice Partnership, Yale, New Haven, USA. Promotes transparency and access to key medical product data.
HealthSense, London, UK. Works for ensuring the highest standards of education and understanding of evidence-based healthcare.
International Institute for Psychiatric Drug Withdrawal, UK. Supports the process of reducing and withdrawing from psychiatric drugs through practice, research and training.
International Society of Drug Bulletins. Worldwide network of bulletins and journals on drugs and therapeutics that are independent of the pharmaceutical industry.
No Gracias. Works for transparency, integrity and equity in health policy, healthcare and biomedical research.
Public Citizen, Washington, USA. Nonprofit consumer advocacy organisation that champions the public interest in the halls of power.